P24.07 Nivolumab and Ipilimumab +/- UV1 Vaccination as 2nd Line Treatment in Patients with Malignant Mesothelioma (the NIPU-Study)

Saved in:
Bibliographic Details
Published inJournal of thoracic oncology Vol. 16; no. 3; p. S380
Main Authors Haakensen, V., Nowak, A., Ellingsen, E., Grundberg, O., Farooqi, S., Mcculloch, T., Cedres, S., Bjaanæs, M., Helland, Å.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.03.2021
Online AccessGet full text

Cover

Author Haakensen, V.
Nowak, A.
Farooqi, S.
Mcculloch, T.
Helland, Å.
Grundberg, O.
Bjaanæs, M.
Ellingsen, E.
Cedres, S.
Author_xml – sequence: 1
  givenname: V.
  surname: Haakensen
  fullname: Haakensen, V.
  organization: Division of Cancer Medicine, Oslo University Hospital, Oslo/NO
– sequence: 2
  givenname: A.
  surname: Nowak
  fullname: Nowak, A.
  organization: National Centre for Asbestos Related Diseases, University of Western Australia, Crawley/ACT/AU
– sequence: 3
  givenname: E.
  surname: Ellingsen
  fullname: Ellingsen, E.
  organization: Ultimovacs Asa, Oslo/NO
– sequence: 4
  givenname: O.
  surname: Grundberg
  fullname: Grundberg, O.
  organization: Karolinska Institutet, Stockholm/SE
– sequence: 5
  givenname: S.
  surname: Farooqi
  fullname: Farooqi, S.
  organization: Division of Cancer Medicine, Oslo University Hospital, Oslo/NO
– sequence: 6
  givenname: T.
  surname: Mcculloch
  fullname: Mcculloch, T.
  organization: Aalborg University Hospital, Ålborg/DK
– sequence: 7
  givenname: S.
  surname: Cedres
  fullname: Cedres, S.
  organization: Medical Oncology, Vall D´hebron Instirute of Oncology (Vhio), Vall D´hebron Barcelona Hospital Campus, Barcelona/ES
– sequence: 8
  givenname: M.
  surname: Bjaanæs
  fullname: Bjaanæs, M.
  organization: Division of Cancer Medicine, Oslo University Hospital, Oslo/NO
– sequence: 9
  givenname: Å.
  surname: Helland
  fullname: Helland, Å.
  organization: Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo/NO
BookMark eNp9kE1PAjEQhhuDiYD-AU89aswubbfdj8SLIX6QAJIIXJtu25WS3ZZsFwxXf7lFOXuad_LOO5l5BqBnndUA3GIUY4TT0TbedhsXE0RwjHCc4vQC9DFjaYSTHPXOGuUpvQID77cIUYZo3gffC0JjlMG5Obh634gSCqvgZGdq0_y2D6MIrtYYroWUxorOOAuFhyRMTY3VcNlq0TXadtBYuAh-kB5-mW4DZ6I2n1YEa6a96za6Nq4R8C4oOJ8sVtFHt1fH-2twWYna65tzHYLVy_Ny_BZN318n46dpJDFFaVSgghZ5zrJKKZ0rVeBEasJEkhGSaYVLplFCqGQVFYilRYWzhCRlKWVZYUXLZAjI317ZOu9bXfFdaxrRHjlG_ESRb_mJIj9R5AjzQDGEHv9COlx2MLrlXoYXpVam1bLjypn_4j_Dm3wf
ContentType Journal Article
Copyright 2021
Copyright_xml – notice: 2021
DBID AAYXX
CITATION
DOI 10.1016/j.jtho.2021.01.616
DatabaseName CrossRef
DatabaseTitle CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1556-1380
EndPage S380
ExternalDocumentID 10_1016_j_jtho_2021_01_616
S1556086421006584
GroupedDBID ---
.55
.XZ
.Z2
0R~
457
53G
5GY
5VS
6I.
9UZ
AACTN
AAEDW
AAFTH
AAIAV
AAKAS
AALRI
AAWTL
AAXUO
ABBUW
ABJNI
ABMAC
ABPMR
ABVKL
ACDDN
ACGFS
ACWDW
ACWRI
ADBBV
ADBIZ
ADEZE
ADZCM
AE3
AENEX
AEXQZ
AFTJW
AFTRI
AGHFR
AHPSJ
AITUG
AIZYK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AWKKM
BOYCO
C45
CS3
DU5
E.X
EBS
EJD
EX3
F5P
FDB
FL-
HZ~
IN~
KD2
NCXOZ
NTWIH
O9-
OFXIZ
OGEVE
OK1
OVD
P2P
ROL
S4S
SSZ
TEORI
V2I
W3M
WOQ
WOW
X7M
0SF
AAYXX
ADVLN
AFETI
AKRWK
CITATION
ID FETCH-LOGICAL-c1406-909498857fdde8dd913ce25a37227ed1b5e0324c5f4a0569f17323bbccbf1d4b3
IEDL.DBID ABVKL
ISSN 1556-0864
IngestDate Thu Sep 12 17:42:06 EDT 2024
Fri Feb 23 02:45:34 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c1406-909498857fdde8dd913ce25a37227ed1b5e0324c5f4a0569f17323bbccbf1d4b3
OpenAccessLink http://www.jto.org/article/S1556086421006584/pdf
ParticipantIDs crossref_primary_10_1016_j_jtho_2021_01_616
elsevier_sciencedirect_doi_10_1016_j_jtho_2021_01_616
PublicationCentury 2000
PublicationDate March 2021
2021-03-00
PublicationDateYYYYMMDD 2021-03-01
PublicationDate_xml – month: 03
  year: 2021
  text: March 2021
PublicationDecade 2020
PublicationTitle Journal of thoracic oncology
PublicationYear 2021
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
SSID ssj0045048
Score 2.3540428
SourceID crossref
elsevier
SourceType Aggregation Database
Publisher
StartPage S380
Title P24.07 Nivolumab and Ipilimumab +/- UV1 Vaccination as 2nd Line Treatment in Patients with Malignant Mesothelioma (the NIPU-Study)
URI https://dx.doi.org/10.1016/j.jtho.2021.01.616
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEF60gngRn1hfzMGDImuzm2STHGtRfLUUtMVb2Fc0orHYevDqL3c2D1AQD96SsANhdvnmm-SbGUIOoiTUnkhimuGGU2TEGVXGeFS5XlmWcclkKZAdiItRcHUf3s-RXlML42SVNfZXmF6idf2kU3uzM8nzzi1GQoGEPMCkpYyj82SBR8LjLbLQPR1f3zSAHIReOUTLrafOoK6dqWReT7NHVwPImeveKdzY89_i07eYc75ClmuyCN3qfVbJnC3WyGK__h2-Tj6HPDjxIhjkJchIBbIwcDnJn_OX8va4Q2E0ZjCWGi3KTQA5BY6rMAm1cNfIzCEvYFi1WJ2C-zYLfSToD04lA307dWVaz_nri4RDvILB5XBEnQLx42iDjM7P7noXtB6qQDXmUoImmM8lcRxGGQJbbEzCfG15KP2I88gapkLrIcnSYRZIJEdJxiKf-0pprTJmAuVvklbxWtgtAtzNUxGZVFzagEslg8wqbZTwtGDGxG1y3LgynVS9M9JGVPaUOsenzvGpx1J0fJuEjbfTHycgRXD_w277n3Y7ZMndVXqyXdKavb3bPSQYM7VfH6Avnh_NeA
link.rule.ids 315,786,790,27602,27957,27958,45698
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9tAEB7RINFeqpaCGuhjDhyo0BLv-n2kqCgpSRSJJOK22pdbIzARCYde-8s764dUJNRDb36NZM2uvvnG_mYG4CjNYxMkecYKWnBGjLhg2tqAad8ry3GhuKoFstNkuIi-X8fXW3De1cJ4WWWL_Q2m12jdXhm03hysynJwRZEwIUIeUdJSx9EXsE1sIM96sH32dXk57gA5ioN6iJZ_nnmDtnamkXndbH76GkDBfffOxI89fy4-_RVzLt7A65Ys4lnzPm9hy1W7sDNpf4e_g98zEZ0GKU7LGmSURlVZHK3K2_KuPj0ZMFwsOS6VIYt6EVCtUdBTlIQ6nHcycywrnDUtVtfov83ihAj6D6-SwYlb-zKt2_L-TuExHeF0NFswr0D89WUPFhff5udD1g5VYIZyqYTllM_lWRanBQFbZm3OQ-NErMJUiNRZrmMXEMkycREpIkd5wdNQhFobowtuIx3uQ6-6r9x7QOHnqSSF0kK5SCitosJpY3USmIRbm_XhpHOlXDW9M2QnKruR3vHSO14GXJLj-xB33pZPdoAkcP-H3cF_2n2Gl8P5ZCzHo-nlIbzydxpt2QfobR4e3UciGxv9qd1MfwCDXNBx
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=P24.07+Nivolumab+and+Ipilimumab+%2B%2F-+UV1+Vaccination+as+2nd+Line+Treatment+in+Patients+with+Malignant+Mesothelioma+%28the+NIPU-Study%29&rft.jtitle=Journal+of+thoracic+oncology&rft.au=Haakensen%2C+V.&rft.au=Nowak%2C+A.&rft.au=Ellingsen%2C+E.&rft.au=Grundberg%2C+O.&rft.date=2021-03-01&rft.issn=1556-0864&rft.volume=16&rft.issue=3&rft.spage=S380&rft_id=info:doi/10.1016%2Fj.jtho.2021.01.616&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_jtho_2021_01_616
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1556-0864&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1556-0864&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1556-0864&client=summon